Preoperative Balloon-Occluded Transcatheter Arterial Chemoembolization Followed by Surgical Resection: Pathological Evaluation of Necrosis

被引:3
|
作者
Kim, Jihoon [1 ,2 ]
Gwon, Dong Il [1 ]
Kim, Yonghun [1 ]
Kim, Gun Ha [1 ]
Kim, Seong Ho [1 ]
Chu, Hee Ho [1 ]
Kim, Jin Hyoung [1 ]
Shin, Ji Hoon [1 ]
Ko, Gi-Young [1 ]
Yoon, Hyun-Ki [1 ]
Teng, Ba-Bie
机构
[1] Univ Ulsan, Res Inst Radiol, Asan Med Ctr, Dept Radiol,Coll Med, Seoul 05502, South Korea
[2] Ajou Univ, Ajou Univ Hosp, Coll Med, Suwon 16499, South Korea
关键词
liver; hepatocellular carcinoma; chemoembolization; balloon occlusion; tumor necrosis; PORTAL-VEIN EMBOLIZATION; HEPATOCELLULAR-CARCINOMA; TRANSARTERIAL CHEMOEMBOLIZATION; COMPUTED-TOMOGRAPHY; CT; THERAPY; TACE; RECURRENCE; HCC;
D O I
10.3390/diseases11040149
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This study investigates the clinical and pathological outcomes of preoperative balloon-occluded transcatheter arterial chemoembolization (B-TACE) in patients with single hepatocellular carcinoma (HCC). The data are from 25 consecutive patients who underwent sequential treatment of subsegmental B-TACE and hepatic surgery for single HCC. Radiological and pathological evaluation of oily subsegmentectomy, defined as the iodized oil-laden necrotic area that includes the entire HCC and surrounding liver parenchyma, were performed. Subsegmental B-TACE was technically successful in all patients. The major and minor complication rates were 8% and 24%, respectively. On the first follow-up computed tomography (CT), oily subsegmentectomy was observed in 18 (72%) out of 25 patients. Apart from one patient showing a partial response, the remaining 24 (96%) patients showed a complete response. Pathological complete necrosis of the HCC was observed in 18 (72%) out of 25 patients with complete or extensive necrosis of the peritumoral liver parenchyma. The remaining seven patients without peritumoral parenchymal necrosis had extensive necrosis of the HCCs. In conclusion, preoperative B-TACE can be a safe and effective method for the treatment of single HCC and a good bridge treatment for subsequent surgical resection. In addition, oily subsegmentectomy itself on the CT can be a good predictor of pathological complete necrosis of the HCC. The findings obtained from this study would provide a potential role of B-TACE in the treatment strategy for single HCC.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma
    Takeshi Hatanaka
    Hirotaka Arai
    Satoru Kakizaki
    World Journal of Hepatology, 2018, (07) : 485 - 495
  • [2] Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma
    Hatanaka, Takeshi
    Arai, Hirotaka
    Kakizaki, Satoru
    WORLD JOURNAL OF HEPATOLOGY, 2018, 10 (07) : 485 - 495
  • [3] The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization
    Pyeong Hwa Kim
    Dong Il Gwon
    Jong Woo Kim
    Hee Ho Chu
    Jin Hyoung Kim
    European Radiology, 2020, 30 : 5650 - 5662
  • [4] The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization
    Kim, Pyeong Hwa
    Gwon, Dong Il
    Kim, Jong Woo
    Chu, Hee Ho
    Kim, Jin Hyoung
    EUROPEAN RADIOLOGY, 2020, 30 (10) : 5650 - 5662
  • [5] Balloon-occluded arterial stump pressure before balloon-occluded transarterial chemoembolization
    Matsumoto, Tomohiro
    Endo, Jun
    Hashida, Kazunobu
    Mizukami, Hajime
    Nagata, Junko
    Ichikawa, Hitoshi
    Kojima, Seiichiro
    Takashimizu, Shinji
    Yamagami, Takuji
    Watanabe, Norihito
    Hasebe, Terumitsu
    MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 2016, 25 (01) : 22 - 28
  • [6] Durable complete response is achieved by balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma
    Shirono, Tomotake
    Iwamoto, Hideki
    Niizeki, Takashi
    Shimose, Shigeo
    Kajiwara, Akira
    Suzuki, Hiroyuki
    Kamachi, Naoki
    Noda, Yu
    Okamura, Shusuke
    Nakano, Masahito
    Kuromatsu, Ryoko
    Murotani, Kenta
    Koga, Hironori
    Torimura, Takuji
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (09) : 2594 - 2604
  • [7] Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Single-Center Experience
    Minami, Yasunori
    Minami, Tomohiro
    Chishina, Hirokazu
    Arizumi, Tadaaki
    Takita, Masahiro
    Kitai, Satoshi
    Yada, Norihisa
    Hagiwara, Satoru
    Tsurusaki, Masakatsu
    Yagyu, Yukinobu
    Ueshima, Kazuomi
    Nishida, Naoshi
    Murakami, Takamichi
    Kudo, Masatoshi
    ONCOLOGY, 2015, 89 : 27 - 32
  • [8] Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma
    Arai, Hirotaka
    Abe, Takehiko
    Takayama, Hisashi
    Toyoda, Mitsuo
    Ueno, Takashi
    Kakizaki, Satoru
    Sato, Ken
    HEPATOLOGY RESEARCH, 2015, 45 (06) : 663 - 666
  • [9] A COMPARATIVE STUDY OF NECROSIS-INDUCING EFFECT ON HEPATOCELLULAR CARCINOMA: BALLOON-OCCLUDED VS. CONVENTIONAL TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION
    Shirono, Tomotake
    Iwamoto, Hideki
    Niizeki, Takashi
    Shimose, Shigeo
    Koga, Hironori
    Torimura, Takuji
    HEPATOLOGY, 2019, 70 : 530A - 530A
  • [10] Epirubicin Is More Effective Than Miriplatin in Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
    Shirono, Tomotake
    Iwamoto, Hideki
    Niizeki, Takashi
    Shimose, Shigeo
    Koga, Hironori
    Torimura, Takufi
    HEPATOLOGY, 2018, 68 : 865A - 865A